CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on September 9, 2007 under Uncategorized | Be the First to Comment
AKT/NF-kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies.
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.
You must be logged in to post a comment.
Add A Comment
You must be logged in to post a comment.